mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.29 |
3e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-06 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-06 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-06 |